ACTRN12618002044202
Recruiting
未知
A multi-centre, pilot randomised controlled trial of a post-acute kidney injury care bundle in patients at high risk of major adverse kidney events
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Acute kidney injury
- Sponsor
- Austin Health
- Enrollment
- 200
- Status
- Recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •ALL of the following:
- •1\. Adult patients admitted to ICU or CCU
- •2\. Kidney Disease Improving Global Outcomes (KDIGO) stage 2 or 3 AKI
- •3\. Alive and independent of RRT for 72 hours at discharge with no plan for RRT following discharge from hospital
- •4\. Written informed consent
Exclusion Criteria
- •ANY of the following:
- •1\. Age less than 18 years
- •2\. Life expectancy \<90 days
- •3\. Baseline eGFR \<30mL/min/1\.73m2 (or no eGFR within 12 months)
- •4\. Kidney transplant recipient
- •5\. AKI due to suspected or proven glomerulonephritis, vasculitis, tubulointerstitial nephritis, thrombotic microangiopathy, pregnancy, myeloma, or hepatorenal syndrome
- •6\. Previously enrolled in this study
- •7\. Previously reviewed by a nephrologist within the preceding 12 months with the intention of ongoing follow\-up
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A pilot multi-centre randomised controlled trial of sequential treatment with Mitoxantrone and Glatiramer Acetate vs Interferon Beta-1a in early active relapsing remitting Multiple SclerosisISRCTN31557558Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)
Active, not recruiting
Phase 1
A pilot multi-centre randomised controlled trial of sequential treatment with Mitoxantrone and Glatiramer Acetate vs. Interferon Beta-1a in early active relapsing remitting Multiple Sclerosis. - UNKEMPTEarly, active relapsing remitting Multiple Sclerosis (RRMS)EUCTR2004-004903-39-GBThe Walton Centre for Neurology and Neurosurgery60
Not yet recruiting
Phase 1
A multicenter, randomized, controlled trial for a novel vaginal microecologic therapy for the treatment of persistent cervical human papillomavirus infection at high riskITMCTR2000003652Shuguang Hospital affiliated to Shanghai University of Traditional Chinese Medicine
Terminated
Not Applicable
Acetabular cup placement in participants requiring total hip replacement or hip resurfacing surgery using the MACNAV navigation system.ACTRN12612000243819Inertial Orthopaedic Navigation Solutions38
Recruiting
Not Applicable
A pilot multicenter randomized study comparing an approach of individualized blood pressure targets to standard care among critically ill patients with shockACTRN12618000571279Intensive Care Unit, John Hunter Hospital50